Xiamen Amoytop Biotech Co., Ltd. Class ASSE: 688278

(688278)"Xiamen Amoytop Biotech Co., Ltd."Announcement on Resolutions of the 25th Meeting of the 9th Board of Directors

Sep 30, 2026 · Issued by Xiamen Amoytop Biotech Co., Ltd. Class A via Shanghai Stock Exchange

Filed with SSE · Stock code 688278 · Sep 30, 2026

Announcement on Resolutions of the 25th Meeting of the 9th Board of Directors

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment

6ix hasn’t read this filing yet.

View original source (Shanghai Stock Exchange)Company analysis

Earlier from Xiamen Amoytop Biotech Co., Ltd. Class A

"Xiamen Amoytop Biotech Co., Ltd."Announcement on Resolutions of the 4th Extraordinary General Meeting in 2026Sep 29
"Xiamen Amoytop Biotech Co., Ltd."Announcement on Joint Investment with Related Parties and Related Party TransactionsSep 12
"Xiamen Amoytop Biotech Co., Ltd."Announcement on Participating in the 2026 Semi-annual Collective Performance Briefing for the STAR Market Innovative Drug IndustrySep 8
"Xiamen Amoytop Biotech Co., Ltd."Announcement on Use of Funds Raised from Convertible Corporate Bonds to Replace Self-raised Funds Previously Invested in Raised Funds Investment Projects and Paid Issuance ExpensesAug 19

All Xiamen Amoytop Biotech Co., Ltd. Class A news releases